Pharmacovigilance deep dive: risk minimisation measures
European Pharmaceutical Review
SEPTEMBER 2, 2022
As does the US Food and Drug Administration (FDA): REMS Assessment: Planning and Reporting Guidance for Industry Draft Guidance. She also has been conducting fundamental research as an academic in several universities, with her last academic position held at Harvard Medical School. About the author. References.
Let's personalize your content